What is the main business of DE Cure Medical Research?

The main business activity of DE Cure Medical Research focuses on general medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 18, 2019.

Where is the headquarters located?

The headquarters is located at: ul. Jana Czeczota 31, 02-607 Warszawa.

Who is on the management board?

The management board includes Jakub Krzysztof Rzepka (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

The company reported a revenue of $150,810 in 2025, which is an increase of 64.0% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of $16,562, meaning the company decreased its profit by 3.8%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $120,925 in 2025, representing 91% of all operating expenses.

DE Cure Medical Researchsp. z o.o.

General medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2019-02-18

Share capital

5,000.00 PLN

Registered address

ul. Jana Czeczota 31, 02-607 Warszawa, Poland

Website

decure.com.pl

Phone

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 234 days for 2021).

202525/03/2026
202421/03/2025
202324/07/2024
202226/06/2023
202106/03/2023
202009/12/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 150.81kMedianUSD 766.37kAverageUSD 2.40m

Net profit

This companyUSD 16.56kMedianUSD 38.88kAverageUSD 163.61k

Operating costs

This companyUSD 132.77kMedianUSD 680.10kAverageUSD 2.18m

Assets

This companyUSD 38.45kMedianUSD 262.36kAverageUSD 1.56m

Industry

Offer

Endometrial regeneration
Ovarian tissue regeneration
Fertility preservation
Ovarian tissue cryopreservation
Egg cell cryopreservation
Gynecological consultations

Website technology

Website

WordPress
Elementor

Analytics and marketing

Google Analytics

Authorized Representatives

Jarosław Bogdan Kaczyński – President of the Management Board

Jakub Krzysztof Rzepka – Vice President of the Management Board

Manner of representation

In the case of a one-person management board, declarations of will are submitted independently by the President of the Management Board. If the management board is a multi-member management board, the company is represented by a member of the management board jointly with another member of the management board or jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Jarosław Bogdan Kaczyńskiage 55	25	$675.31	50%
Jakub Krzysztof Rzepkaage 44	25	$675.31	50%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Pragamedsp. z o.o.	$283,510.33	pragamed.pl
Nowasp. z o.o.	$251,827.86	nowaclinic.pl
Portamedicasp. z o.o.	$241,898.26	portamedica.pl
Noble Healthy Centersp. z o.o.	$193,526.77	noblehealthy.pl
Klinika Sanosp. z o.o.	$188,923.44	alergoland.pl
Doktor Beata Dethloffsp. z o.o.	$146,758.01	drbeatadethloff.pl
Znajomaclinicasp. z o.o.	$105,970.59	znajomaklinika.pl
Idealesp. z o.o.	$80,582.55	ideale.pl
ZDRO Techsp. z o.o.	$4,137.92	zdro.tech
Etualsp. z o.o.	$2,012.08	etual.pl

FAQ

Last updated: 2026-03-25